CompletedPhase 1NCT01241162
Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
Studying Embryonal rhabdomyosarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Louisville
- Principal Investigator
- Kenneth G Lucas, MDUniversity of Louisville, Kosairs Charities Pediatric Clinical Research Unit
- Intervention
- Autologous dendritic cell vaccine with adjuvant(biological)
- Enrollment
- 19 enrolled
- Eligibility
- 1-24 years · All sexes
- Timeline
- 2010 – 2016
Study locations (1)
- University of Louisville, Kosair Charities Pediatric Clinical Research Unit, Louisville, Kentucky, United States
Collaborators
Solving Kids' Cancer
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01241162 on ClinicalTrials.govOther trials for Embryonal rhabdomyosarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT06541262Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsMilton S. Hershey Medical Center
- RECRUITINGPHASE1NCT04337177Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid TumorsValent Technologies, LLC